Harry Lesmana

656 total citations
23 papers, 107 citations indexed

About

Harry Lesmana is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Harry Lesmana has authored 23 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Genetics. Recurrent topics in Harry Lesmana's work include Erythrocyte Function and Pathophysiology (6 papers), Blood disorders and treatments (4 papers) and Blood groups and transfusion (4 papers). Harry Lesmana is often cited by papers focused on Erythrocyte Function and Pathophysiology (6 papers), Blood disorders and treatments (4 papers) and Blood groups and transfusion (4 papers). Harry Lesmana collaborates with scholars based in United States, Canada and Netherlands. Harry Lesmana's co-authors include Kim E. Nichols, Robert J. Hopkin, Marcin W. Włodarski, Kevin E. Bove, Mark B. Schapiro, T. Burrow, Barbara Hallinan, Sara Lewis, Seyed Ali Hosseini and Qian Liu and has published in prestigious journals such as Blood, Clinical Cancer Research and Human Mutation.

In The Last Decade

Harry Lesmana

19 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Lesmana United States 7 35 26 26 17 13 23 107
Marie‐Agnès Collonge‐Rame France 5 23 0.7× 36 1.4× 22 0.8× 13 0.8× 19 1.5× 11 69
Maiko Narahara Japan 4 59 1.7× 14 0.5× 31 1.2× 14 0.8× 5 0.4× 5 112
Keren Machol United States 6 58 1.7× 64 2.5× 21 0.8× 7 0.4× 17 1.3× 11 123
Virginie Saillour Canada 7 116 3.3× 38 1.5× 65 2.5× 18 1.1× 13 1.0× 10 191
Insha Mushtaq United States 9 90 2.6× 10 0.4× 22 0.8× 30 1.8× 7 0.5× 12 147
Flore Zufferey Switzerland 5 67 1.9× 13 0.5× 67 2.6× 13 0.8× 6 0.5× 5 150
Georgina L. Ryland Australia 3 60 1.7× 20 0.8× 22 0.8× 16 0.9× 9 0.7× 4 98
Robert J. Autry United States 6 68 1.9× 15 0.6× 26 1.0× 25 1.5× 4 0.3× 12 127
Himanshu Chheda Finland 4 33 0.9× 47 1.8× 27 1.0× 29 1.7× 27 2.1× 4 124
Milan Hiersche Germany 4 68 1.9× 38 1.5× 73 2.8× 5 0.3× 6 0.5× 5 138

Countries citing papers authored by Harry Lesmana

Since Specialization
Citations

This map shows the geographic impact of Harry Lesmana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Lesmana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Lesmana more than expected).

Fields of papers citing papers by Harry Lesmana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Lesmana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Lesmana. The network helps show where Harry Lesmana may publish in the future.

Co-authorship network of co-authors of Harry Lesmana

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Lesmana. A scholar is included among the top collaborators of Harry Lesmana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Lesmana. Harry Lesmana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Maese, Luke, Marcin W. Włodarski, Alison A. Bertuch, et al.. (2024). Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy. Clinical Cancer Research. 30(19). 4286–4295. 3 indexed citations
3.
Keller, Nancy P., Julian Midgley, Harry Lesmana, et al.. (2024). Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients. Orphanet Journal of Rare Diseases. 19(1). 355–355. 2 indexed citations
4.
MacFarland, Suzanne P., Kami Wolfe Schneider, Roland P. Kuiper, et al.. (2024). Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group. Clinical Cancer Research. 30(20). 4566–4571. 6 indexed citations
5.
Nakano, Yoshiko, Roland P. Kuiper, Kim E. Nichols, et al.. (2024). Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders. Clinical Cancer Research. 30(22). 5009–5020. 8 indexed citations
6.
Wright, Nicola, James R. Eshleman, Julian Midgley, et al.. (2024). Sphingosine phosphate lyase insufficiency syndrome as a primary immunodeficiency state. Advances in Biological Regulation. 94. 101058–101058. 2 indexed citations
8.
Lesmana, Harry, et al.. (2024). Evans syndrome in the background of 22q11.2 deletion syndrome. Pediatric Blood & Cancer. 71(7). e31049–e31049.
9.
Carraway, Hetty E., Harry Lesmana, John C. Molina, et al.. (2024). JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms. Blood Advances. 9(7). 1534–1543. 1 indexed citations
10.
Lesmana, Harry, et al.. (2023). CBL Syndrome: At the Intersection of Inborn Error of Immunity and Cancer Predisposition. Clinical Immunology. 250. 109564–109564.
11.
12.
Lesmana, Harry, et al.. (2021). COVID-19 Pandemic and MSMEs in Indonesia: Impact and Policy Responses. 10(2). 143–171. 8 indexed citations
13.
Lesmana, Harry, Timothy W. Jacobs, Sara Lewis, et al.. (2021). Eltrombopag in children with severe aplastic anemia. Pediatric Blood & Cancer. 68(8). e29066–e29066. 17 indexed citations
14.
Majhail, Navneet S., et al.. (2021). Germline Biallelic Loss in MBD4 leading to Early Onset AML with Hyper-Mutator Genomic Signature. Blood. 138(Supplement 1). 3385–3385. 3 indexed citations
15.
Lesmana, Harry, Sara Lewis, Sushree Sangita Sahoo, et al.. (2020). Germline Gain-of-Function JAK3 Mutation in Familial Chronic Lymphoproliferative Disorder of NK Cells. Blood. 136(Supplement 1). 9–10. 10 indexed citations
16.
Szafrański, Przemysław, Harry Lesmana, Robert J. Hopkin, et al.. (2019). Novel parent-of-origin-specific differentially methylated loci on chromosome 16. Clinical Epigenetics. 11(1). 60–60. 14 indexed citations
17.
Lesmana, Harry, Seyed Ali Hosseini, T. Burrow, et al.. (2018). CNTNAP1-Related Congenital Hypomyelinating Neuropathy. Pediatric Neurology. 93. 43–49. 14 indexed citations
18.
Lesmana, Harry, Lisa Dyer, Xia Li, et al.. (2017). Alu element insertion inPKLRgene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients. Human Mutation. 39(3). 389–393. 5 indexed citations
19.
Lesmana, Harry, et al.. (2017). RGL2 Deficiency Impairs Human Erythropoiesis By Altering Terminal Erythroid Differentiation and Apoptosis. Blood. 130(Suppl_1). 8–8. 2 indexed citations
20.
Lesmana, Harry, Georgios E. Christakopoulos, Katie Seu, et al.. (2016). Clinical Application of Massively Parallel Sequencing in the Diagnosis of Hereditary Hemolytic and Dyserythropoietic Anemias. Blood. 128(22). 4746–4746. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026